New Tools in the Infectious Disease Toolbox: Combatting Future Biological Threats

4:15 PM - 5:15 PM (EDT), Wednesday, June 7, 2023 ・ Session Room 208
COVID-19 is here to stay. With current prevention and treatment strategies, the virus will continue to evolve and mutate around established human immunity which rapidly wanes within months of vaccine or virus exposure. No one solution, including vaccines, is effective on its own to manage the health threat that COVID-19 poses for these vulnerable populations.

Hear from a diverse panel of experts about the need for new, more durable tools, such as mAbs (monoclonal antibodies), to better prevent and treat COVID-19 and avoid hospitalization and death in susceptible demographics. Panelists will review significant challenges related to vaccines and antivirals, the body’s inability to mount a strong and durable defense and identify opportunities for improved solutions and health outcomes with therapeutic antibodies and other solutions.
Conquest Advisors
CEO and Founder
Blue Lake Biotechnology
Chief, Antivirals and Antitoxins
Global Public Health R&D Policy and Engagement Lead
Johnson & Johnson